ANZSN Annual Scientific Meeting Online Provisional Program
|
|
Registration to the online ASM includes access to the full program below, the Networking Hub, Exhibition Hall, Resource Gallery and all virtual networking sessions. Attendees do not need to identify which sessions they wish to attend before the event. Click here to register. The ASM aims to provide all sessions on-demand to registered delegates for a 3 months post event, dependent on speaker consent. Where consent has not been received and the session will only be available live on the day of presentation and this will be indicated in the program below by 23rd August 2021. Program times are listed in AEST. To convert program times to your timezone, CLICK HERE
|
Tuesday, 24th August 2021 |
| Platform open and access sent to attendees If you have not received your log in please check you junk mail folder. Login to the portal here Not registered? There’s still time! Register now |
Monday, 30th August 2021 |
| 0900-0930 Platform Orientation & Exhibition Open |
| 0930-0955 ICEBREAKER DELEGATE NETWORKING |
| 1000 – 1115 PLENARY #1 Chair: Neil Boudville, ANZSN President |
| 1000-1015 Opening Address Neil Boudville, President, ANZSN  |
| 1015-1115 Plenary Speaker PODOCYTE LIPIDS AND FATTY KIDNEY DISEASE Dr Alessia Fornoni, USA  |
| 1115-1145 Refreshment & Exhibition Break |
| 1145-1315 CONCURRENT SESSION #1 | ||||
| TIME | ETHICAL DECISION MAKING IN NEPHROLOGY Chair: Cathie Lane |
TOM BARBOUR MEMORIAL SESSION Chair: Nigel Toussaint |
BASIC SCIENCE SYMPOSIUM AKI – CKD & BACK AGAIN Chair: Jean Tan |
IMMUNITY & INFLAMMATION Chair: Poh-Yi Gan |
| 1145-1215 | ETHICS OF RISK ACCEPTANCE IN LIVING KIDNEY DONATION – WHO SHOULD DECIDE? Dominique Martin |
INTRODUCTION Nigel Toussaint |
TUBULAR ENERGY METABOLISM IN THE AKI-CKD SPECTRUM Samir Parikh, USA |
IMMUNITY AND INFLAMMATION IN THE KIDNEY Menna Clatworthy, UK |
| 1215-1245 | END OF LIFE DECISION MAKING: BALANCING PATIENT AUTONOMY AND DIALYSIS WITHDRAWAL Kathryn Ducharlet |
KIDNEY INJURY IN C3 GLOMERULOPATHY Matthew Pickering |
RENAL REPLACEMENT THERAPY IN ACUTELY ILL PATIENTS Emily See |
THE SECRET LIFE OF NEUTROPHILS: TRACKING NEUTROPHILS IN INFLAMMATION, INFECTION AND CANCER USING INTRAVITAL MICROSCOPY Tatyana Chtanova |
| 1245-1315 |
ETHICAL ISSUES IN END STAGE RENAL DISEASE FROM THE BIRTH OF DIALYSIS TO COVID-19 |
TOWARDS PERSONALIZED MEDICINE IN IgA NEPHROPATHY Sean Barbour, CAN |
INFLAMMATION AND CELL DEATH IN ACUTE KIDNEY INJURY David Nikolic-Paterson |
MINERAL BEHAVING BADLY Edward Smith |
| 1315-1340 Refreshment & Exhibition Break |
||||
| 1340- 1550 PLENARY #2 YOUNG INVESTIGATOR AWARD Chair: Richard Kitching |
| BASIC SCIENCE |
| INABILITY TO INCREASE FATTY ACID OXIDATION WORSENS ACUTE KIDNEY INJURY AND IMPACTS THE BENEFIT OF METFORMIN Geoffrey Harley |
| ADOPTIVE TOLEROGENIC DENDRITIC CELL THERAPY PROTECTS AGAINST RENAL ISCHEMIA REPERFUSION INJURY Jennifer Li |
| TARGETING CD47 PROTECTS AGAINST CARDIORENAL SYNDROME Katie Trinh |
| ROLE OF DNA DAMAGE RESPONSE (DDR) SIGNALLING IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD) Jennifer Zhang |
| CLINICAL SCIENCE |
| MACHINE LEARNING IMPROVES UPON CLINICIANS’ PREDICTION OF END-STAGE KIDNEY FAILURE Daniel Christiadi |
| CAN PODOCYTE NUMBER AND DENSITY PREDICT THE RESPONSE TO THERAPY IN PATIENTS WITH PRIMARY FSGS? Natasha De Zoysa |
| LESSONS FROM A 10-YEAR RETROSPECTIVE REVIEW OF PANCREAS TRANSPLANTATION IN AUSTRALIA AND NEW ZEALAND Jonathan Ling |
| TRIMETHOPRIM–SULFAMETHOXAZOLE PHARMACOKINETIC EVAULATION IN ADULT KIDNEY TRANSPLANT RECEIPIENTS Carla Scuderi |
| 1550-1615 Refreshment & Exhibition Break |
| 1745 ASM Program Day 1 Concludes |
| 1745-1845 2021 ANZSN Annual General Meeting All members welcome |
Tuesday, 31st August 2021 |
| 0900 Platform & Exhibition Open |
| 0930-0955 ICEBREAKER DELEGATE NETWORKING |
| 1000 – 1100 PLENARY #3 Chair: Natasha Rogers |
| 0955-1000 Welcome |
| 1000-1100 Plenary Speaker NAD+ AND RENAL STRESS DEFENSE – BENCH TO BEDSIDE Samir Parikh, USA  |
| 1100-1130 Refreshment & Exhibition Break |
| 1130-1300 CONCURRENT SESSION #3 | ||||
| TIME | APSN SYMPOSIUM Chair: Muh Geot Wong |
PAEDIATRIC SYMPOSIUM FROM GENETICS TO GENE THERAPY Chair: Stephen Alexander |
INTERVENTIONAL SYMPOSIUM Chair: Eddie Tan |
CLINICAL TRIAL UPDATE SYMPOSIUM Chair: Matthew Roberts |
| 1130-1200 | UPDATES ON POST INFECTIOUS GN Rosnawati Yahya |
miRNA IN KIDNEY DEVELOPMENT Jacqueline Ho, USA |
PROCEEDURAL CERTIFICATION AND ACCREDITATION IN INTERVENTIONAL NEPHROLOGY Steve May |
CLINICAL TRIALS IN NEPHROLOGY Meg Jardine AKTN SYMPOSIUM TRIAL UPDATE |
| 1200-1230 | THERAPEUTIC TARGET FOR MITOCHONDRIA METABOLISM IN KIDNEY DISEASE Reiko Inagi |
STEROID-RESISTANT NEPHROTIC SYNDROME Hugh McCarthy |
FISTULA MATURATION AND DYSFUNCTIONAL FISTULAS: HOW TO APPROACH Catherine Wilkinson |
|
| PD CATHETER INSERTION AND COMPLICATIONS David Voss |
||||
| 1230-1300 | SOLID ORGAN TRANSPLANT REGISTRY IN ASIA (ASTREG) Curie Ahn |
GENE THERAPY FOR CYSTINOSIS Stephanie Cherqui |
FISTULA CANNULATION: TECHNIQUES AND COMPLICATIONS Liz Coroneos |
|
| 1300-1330 Refreshment & Exhibition Break |
||||
| 1515-1615 PLENARY #4 Chair: Jaqueline Phillips |
|
1515-1615 Plenary Speaker VASCULAR REMODELING IN HYPERTENSION AND IMMUNE MECHANISMS |
| 1615 – 1645 DELEGATE GROUP NETWORKING |
| 1645 ASM Day 2 Concludes |
Wednesday, 1st September 2021 |
| 0830 Platform & Exhibition Open |
| 0900-0930 ICEBREAKER DELEGATE NETWORKING |
| 0930- 1100 CONCURRENT SESSION #5 | ||||
| TIME | UPDATES IN NEPHROLOGY SYMPOSIUM Chair: Sradha Kotwal |
BIG DATA IN NEPHROLOGY SYMPOSIUM Chair: Karen Keung |
EQUITY & DIVERSITY SYMPOSIUM Chair: Jaquelyne Hughes |
TRANSPLANTATION UPDATE SYMPOSIUM Chair: Rathika Krishnasamy |
| 0930-1000 | COVID VACCINATION AND KIDNEY DISEASE Janine Trevillyan |
BIG DATA AND REGISTRIES – DO THEY NEED EACH OTHER? Stephen McDonald |
CONSIDER GUIDELINES Tania Huria |
LATE ALLOGRAFT REJECTIONG – WHAT TO DO Brian Nankivell |
| 1000-1030 | CARI GUIDELINES – MAKING GUIDELINES LIVING David Tunnicliffe |
HARNESSING BIOINFORMATICS IN KIDNEY Jean Yang |
HOW GOATS AND GUTS CAN MAKE YOU GLOBAL Alessia Fornoni |
KIDNEY REGROWTH AFTER DONATION Jonathan Gleadle |
| INVOLVING CONSUMERS IN CLINICAL PRACTICE GUIDELINES Nicki Scholes-Robertson, Chandana Guha |
||||
| 1030-1100 |
NATIONAL BEST PRACTICE GUIDELINES FOR ENVIRONMENTALLY SUSTAINABLE DESIGN (ESD) OF DIALYSIS UNITS Matthew Sypek |
SPATIAL TRANSCRIPTOMIC AND THE KIDNEY Quan Nguyen |
UPDATE FROM THE EQUITY, DIVERSITY AND INCLUSIVITY COMMITTEE Anna Francis |
CARDIOVASCULAR DISEASE AND KIDNEY TRANSPLANTATION Helen Pilmore |
| 1100-1130 Refreshment & Exhibition Break |
||||
| 1330-1500 PLENARY #5 Focus on First Nations Chair: Carol Pollock |
| REPORT FROM THE NATIONAL INDIGENOUS KIDNEY TRANSPLANT TASKFORCE Jaquelyne Hughes & Stephen McDonald |
| INDIGENOUS PATIENTS – HOW WE NEED TO DO BETTER Curtis Walker |
| RETURN TO COUNTRY STUDY Yomei Jones & Cilla Preece |
| 1500-1515 Refreshment & Exhibition Break |
| 1515-1645 PLENARY #6 Chair: David Johnson, Incoming ANZSN President Award Presentations |
| Leadership Award David Harris, NSW  |
| TJ Neale Award Presentation Meg Jardine, NSW  |
| Jacquot Award Paul Lawton & Karen Keung |
| 1645-1650 Changeover Break |
| 1650-1715 PLENARY #7 Chair: David Johnson, Incoming ANZSN President President’s Overview of 2021 ASM – highlights, hot topics and future directions |
| Award Presentations Handover & Closing |
| 1715 ASM Day 3 Concludes |